Corporate ActionJul 22, 2026, 06:07 AM
Clinuvel ADS to Commence Trading on Nasdaq Global Select
AI Summary
Clinuvel Pharmaceuticals Limited announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market under the ticker symbol CUVL. This follows the SEC's declaration of effectiveness for the Company's 20-F Registration Statement and Nasdaq's approval. The existing over-the-counter American Depositary Receipt (ADR: CLVLY) will be upgraded from Level I to Level II, trading on the Nasdaq Global Select Market, which is expected to increase visibility among U.S. investors. The Company does not plan to raise capital or issue new shares with this upgrade.
Key Highlights
- Clinuvel's American Depositary Share (ADS) to commence trading on Nasdaq.
- ADS will trade under the ticker symbol CUVL.
- Existing Level I ADR (CLVLY) to be upgraded to Level II ADS.
- CUVL will trade on the Nasdaq Global Select Market.
- No new capital will be raised, and no new shares will be issued as part of the program.
Price Impact